Search Results

There are 26717 results for: content related to: Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study

  1. Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 117–125, M Dobrinas, J Cornuz, B Oneda, M Kohler Serra, M Puhl and CB Eap

    Version of Record online : 18 MAY 2011, DOI: 10.1038/clpt.2011.70

  2. Influence of Environmental and Genetic Factors on CYP1A2 Activity in Individuals of South Asian and European Ancestry

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 511–519, V Perera, A S Gross and A J McLachlan

    Version of Record online : 5 SEP 2012, DOI: 10.1038/clpt.2012.139

  3. You have free access to this content
    Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2

    British Journal of Clinical Pharmacology

    Volume 54, Issue 5, November 2002, Pages: 540–543, Xing-Mei Han, Dong-Sheng Ouyang, Xiao-Ping Chen, Yan Shu, Chang-Hong Jiang, Zhi-Rong Tan and Hong-Hao Zhou

    Version of Record online : 11 NOV 2002, DOI: 10.1046/j.1365-2125.2002.01686.x

  4. You have free access to this content
    Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study

    International Journal of Cancer

    Volume 130, Issue 5, 1 March 2012, Pages: 1174–1183, Li Tao, Yong-Bing Xiang, Kenneth K. Chan, Renwei Wang, Yu-Tang Gao, Mimi C. Yu and Jian-Min Yuan

    Version of Record online : 21 JUN 2011, DOI: 10.1002/ijc.26121

  5. Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations

    Journal of Molecular Recognition

    Volume 29, Issue 8, August 2016, Pages: 370–390, Siddharth S. Kesharwani, Prajwal P. Nandekar, Preeti Pragyan, Vijay Rathod and Abhay T. Sangamwar

    Version of Record online : 25 FEB 2016, DOI: 10.1002/jmr.2537

  6. Haplotypes in the 5′-untranslated region of the CYP1A2gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism

    Environmental and Molecular Mutagenesis

    Volume 54, Issue 2, March 2013, Pages: 124–132, Guillermo Gervasini, Roza Ghotbi, Eleni Aklillu, Carmen San Jose, Agustin Cabanillas, Junko Kishikawa, Julio Benitez and Juan Antonio Carrillo

    Version of Record online : 9 NOV 2012, DOI: 10.1002/em.21747

  7. You have free access to this content
    Uroporphyria in mice: Thresholds for hepatic CYP1A2 and iron


    Volume 35, Issue 4, April 2002, Pages: 912–921, Nadia Gorman, Kerry L. Ross, Heidi S. Walton, William J. Bement, Juliana G. Szakacs, Glenn S. Gerhard, Timothy P. Dalton, Daniel W. Nebert, Richard S. Eisenstein, Jacqueline F. Sinclair and Peter R. Sinclair

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.32487

  8. You have free access to this content
    Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population

    British Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2000, Pages: 145–151, Dong-Shen Ou-Yang, Song-Lin Huang, Wei Wang, Hong-Guang Xie, Zhen-Hua Xu, Yan Shu and Hong-Hao Zhou

    Version of Record online : 5 APR 2002, DOI: 10.1046/j.1365-2125.2000.00128.x

  9. You have free access to this content
    Assessment of CYP1A2 Activity in Clinical Practice: Why, How, and When?

    Basic & Clinical Pharmacology & Toxicology

    Volume 97, Issue 3, September 2005, Pages: 125–134, Mirko S. Faber, Alexander Jetter and Uwe Fuhr

    Version of Record online : 26 AUG 2005, DOI: 10.1111/j.1742-7843.2005.pto_973160.x

  10. You have free access to this content
    Involvement of CYP1A2 in mexiletine metabolism

    British Journal of Clinical Pharmacology

    Volume 46, Issue 1, July 1998, Pages: 55–62, M. Nakajima, K. Kobayashi, N. Shimada, S. Tokudome, T. Yamamoto and Y. Kuroiwa

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00048.x

  11. Differential mechanisms for the inhibition of human cytochrome P450 1A2 by apigenin and genistein

    Journal of Biochemical and Molecular Toxicology

    Volume 24, Issue 4, July/August 2010, Pages: 230–234, Hideaki Shimada, Masashi Eto, Misa Ohtaguro, Michihiro Ohtsubo, Yosuke Mizukami, Tsuyoshi Ide and Yorishige Imamura

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jbt.20328

  12. Characterization of adjacent E-box and nuclear factor 1-like DNA binding sequence in the human CYP1A2 promoter

    Journal of Biochemical and Molecular Toxicology

    Volume 19, Issue 2, April 2005, Pages: 78–86, Marta J. Narvaez, Garret R. Anderson, George V. Pickwell and Linda C. Quattrochi

    Version of Record online : 22 APR 2005, DOI: 10.1002/jbt.20063

  13. Toward the evaluation of function in genetic variability: Characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus

    Human Mutation

    Volume 25, Issue 2, February 2005, Pages: 196–206, Zhengwen Jiang, Timothy P. Dalton, Li Jin, Bin Wang, Yutaka Tsuneoka, Howard G. Shertzer, Ranjan Deka and Daniel W. Nebert

    Version of Record online : 10 JAN 2005, DOI: 10.1002/humu.20134

  14. You have free access to this content
    Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population

    British Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2003, Pages: 321–324, Samar I. Hamdy, Masahiro Hiratsuka, Kaori Narahara, Naomi Endo, Mervat El-Enany, Nadia Moursi, Mohammed S.-E. Ahmed and Michinao Mizugaki

    Version of Record online : 10 MAR 2003, DOI: 10.1046/j.1365-2125.2003.01787.x

  15. In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening Performance

    Molecular Informatics

    Volume 34, Issue 6-7, June 2015, Pages: 431–457, Teresa Kaserer, Martina Höferl, Klara Müller, Sebastian Elmer, Markus Ganzera, Walter Jäger and Daniela Schuster

    Version of Record online : 23 JUN 2015, DOI: 10.1002/minf.201400192

  16. Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans

    Journal of Pharmacy and Pharmacology

    Volume 65, Issue 2, February 2013, Pages: 264–270, Vidya Perera, Annette S. Gross and Andrew J. McLachlan

    Version of Record online : 24 SEP 2012, DOI: 10.1111/j.2042-7158.2012.01594.x

  17. Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva

    Biomedical Chromatography

    Volume 29, Issue 11, November 2015, Pages: 1657–1663, Elias Begas, Evangelos Kouvaras, Andreas K. Tsakalof, Maria Bounitsi and Eftihia Konstadinos Asprodini

    Version of Record online : 19 APR 2015, DOI: 10.1002/bmc.3475

  18. Factors affecting interindividual differences in clozapine response: a review and case report

    Human Psychopharmacology: Clinical and Experimental

    Volume 26, Issue 3, April 2011, Pages: 177–187, Francesco Saverio Bersani, Enrico Capra, Amedeo Minichino, Rossella Pannese, Nicoletta Girardi, Isabella Marini, Roberto Delle Chiaie and Massimo Biondi

    Version of Record online : 31 MAR 2011, DOI: 10.1002/hup.1191

  19. Development of a whole-cell screening system for evaluation of the human CYP1A2-mediated metabolism

    Biotechnology and Bioengineering

    Volume 108, Issue 12, December 2011, Pages: 2932–2940, Chih-Chieh Chu, Kao-Lu Pan, Hsien-Tsung Yao and John Tsu-An Hsu

    Version of Record online : 1 AUG 2011, DOI: 10.1002/bit.23256

  20. Mice as Clinically Relevant Models for the Study of Cytochrome P450-dependent Metabolism

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 6, June 2008, Pages: 818–828, S Muruganandan and CJ Sinal

    Version of Record online : 19 MAR 2008, DOI: 10.1038/clpt.2008.50